Skip to main content
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC logo

OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC — Investor Relations & Filings

Ticker · OCTHF ISIN · GB00BMVMRB86 LEI · 2138005SRWT4998BCE35 IL Manufacturing
Open in API
Filings indexed 176 across all filing types
Latest filing 2023-01-03 Regulatory Filings
Country GB United Kingdom
Listing IL OCTHF

About OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC

https://www.oxcantech.com/

Oxford Cannabinoid Technologies Holdings PLC was a biopharmaceutical company engaged in the research, development, and commercialization of cannabinoid-based prescription medicines. The company's primary focus was on the pain market, with the goal of developing non-addictive medications to reduce reliance on opioids. Its drug discovery programs targeted the endocannabinoid system (ECS) and included a portfolio of proprietary cannabinoid derivatives, in-licensed compounds, and new chemical entities. According to its website, the company ceased trading and entered administration in May 2025.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number' and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content describes a 'Price Monitoring Extension' for a security, which is a specific, short operational announcement related to trading mechanics, not a comprehensive financial report (like 10-K or IR) or a formal shareholder communication (like DEF 14A or AGM-R). Since it is a general regulatory announcement disseminated via the RNS system that doesn't fit into the more specific categories (like DIV, DIRS, ER, etc.), the most appropriate classification is the general regulatory filing fallback category.
2023-01-03 English
Second Price Monitoring Extn
Share Issue/Capital Change Classification · 99% confidence The document is very short (1950 characters) and contains the header 'RNS Number : 2494L' and mentions 'RNS, the news service of the London Stock Exchange'. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific type of market announcement. Since it is a direct, short announcement disseminated via the RNS system and doesn't fit neatly into the specific financial report categories (like 10-K, ER, IR), it falls best under the general regulatory announcement category, RNS.
2022-12-29 English
Price Monitoring Extension
Regulatory Filings Classification · 95% confidence The document is very short (1933 characters) and contains the header 'RNS Number : 2486L' and mentions 'RNS, the news service of the London Stock Exchange'. The content describes a 'Price Monitoring Extension' which is a specific operational announcement related to trading on the exchange, rather than a comprehensive financial report (like 10-K or IR) or a standard corporate action (like DIV or ER). Since it is a general regulatory announcement disseminated via the RNS system that doesn't fit into the more specific categories (like DIRS, MANG, or DIV), the most appropriate classification is the general Regulatory Filings fallback category.
2022-12-29 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document explicitly states 'Director Dealings' in the header section and details the purchase of ordinary shares by Clarissa Sowemimo-Coker, the Interim Chief Executive Officer. The content includes tables detailing the number of shares purchased, price per share, and the resulting holding, which is characteristic of insider transaction reporting required for Persons Discharging Managerial Responsibilities (PDMR). This directly corresponds to the definition of Director's Dealing (DIRS). The presence of the RNS Number and the reference to Article 19(1) of Regulation (EU) No. 596/2014 confirms it is a regulatory filing related to insider transactions.
2022-12-15 English
Proactive research analyst John Savin on Oxford Cannabinoid Technologies
Regulatory Filings Classification · 100% confidence The document is very short (1516 characters) and appears to be a distribution notice from EQS News, mentioning a 'Corporate News' about a research analyst's coverage of Oxford Cannabinoid Technologies Holdings PLC. It does not contain the content of a specific financial report (like 10-K, IR, ER) but rather announces the dissemination of news via the EQS service. Since it is a general regulatory/news announcement that doesn't fit the specific categories like ER, CT, or DIV, and it's not explicitly announcing the publication of a major report (like RPA), the most appropriate fallback category is Regulatory Filings (RNS), which covers general regulatory announcements.
2022-12-15 English
Oxford Cannabinoid Technologies 'very confident' heading into 2023
Earnings Release Classification · 99% confidence The document is a short news release dated December 15, 2022, originating from EQS-News, which explicitly states it is a 'Dissemination of a Corporate News' and mentions that its services include 'Regulatory Announcements, Financial/Corporate News and Press Releases.' The content is a brief update ('Oxford Cannabinoid Technologies ‘very confident’ heading into 2023') and does not contain the detailed financial statements of an Annual Report (10-K) or Interim Report (IR), nor is it a transcript (CT) or a specific filing like DIRS or DIV. Given its nature as a general corporate news item distributed via a regulatory news service (EQS), and lacking a more specific classification match, the most appropriate general category is Regulatory Filings (RNS), which serves as the fallback for miscellaneous regulatory announcements. FY 2022
2022-12-15 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.